Colchicine-sensitive nephrotic syndrome due to AA amyloidosis

References

• Paydas S. Report on 59 patients with renal amyloidosis. Int Urol Nephrol 1999;31:619–631.
   PubMedGoogle Scholar
• Livneh A, Zemer D, Langevitz P, Shemer J, Sohar E, Pras M. Colchicine in the treatment of AA and AL amyloidosis. Semin Arthritis Rheum 1993;23:206–214.
   PubMed Web of Science ®Google Scholar
• Dember LM, Hawkins PN, Hazenberg BP, Gorevic PD, Merlini G, Butrimiene I, Livneh A, et al.; Eprodisate for AA Amyloidosis Trial Group. Eprodisate for the treatment of renal disease in AA amyloidosis. N Engl J Med 2007;356:2349–2360.
   PubMed Web of Science ®Google Scholar
• Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum 1994;37:1804–1811.
   PubMed Web of Science ®Google Scholar
• Engin-Ustün Y, Ustün Y, Karabulut AB, Ozkaplan E, Meydanli MM, Kafkasli A. Serum amyloid A levels are increased in pre-eclampsia. Gynecol Obstet Invest 2007;64:117–120.
   Google Scholar
• Cicarelli LM, Perroni AG, Zugaib M, de Albuquerque PB, Campa A. Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 during and after delivery. Mediators Inflamm 2005;2005:96–100.
   PubMed Web of Science ®Google Scholar
• Kovacevic A, Hammer A, Sundl M, Pfister B, Hrzenjak A, Ray A, Ray BK, et al. Expression of serum amyloid A transcripts in human trophoblast and fetal-derived trophoblast-like choriocarcinoma cells. FEBS Lett 2006;580:161–167.
   PubMed Web of Science ®Google Scholar
• Shtrasburg S, Pras M, Dolitzky M, Pariente C, Gal R, Livneh A. Pregnancy and amyloidosis: II. Suppression of amyloidogenesis during pregnancy. J Lab Clin Med 2000;136:314–319.
   Google Scholar
• Maury CP, Törnroth T, Wegelius O. Is amyloid A (AA) amyloidosis always secondary? Ann Rheum Dis 1985;44:273–276.
   PubMed Web of Science ®Google Scholar
• Pras M, Zaretzky J, Frangione B, Franklin EC. AA protein in a case of “primary” or “idiopathic” amyloidosis. Am J Med 1980;68:291–294.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007;356:2361–2371.
   PubMed Web of Science ®Google Scholar
• Blum A, Gafni J, Sohar E, Shibolet S, Heller H. Amyloidosis as the sole manifestation of familial Mediterranean fever (FMF). Further evidence of its genetic nature. Ann Intern Med 1962;57:795–799.
   PubMed Web of Science ®Google Scholar
• Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001;9:473–483.
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001;358:24–29.
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Hawkins PN. Eprodisate in AA amyloidosis. N Engl J Med 2007;357:1153–1154.
   Google Scholar
• Shtrasburg S, Pras M, Gal R, Salai M, Livneh A. Inhibition of the second phase of amyloidogenesis in a mouse model by a single-dose colchicine regimen. J Lab Clin Med 2001;138:107–111.
   Google Scholar
• Ozdemir BH, Ozdemir FN, Sezer S, Sar A, Haberal M. Does colchicine have an antifibrotic effect on development of interstitial fibrosis in renal allografts of recipients with familial Mediterranean fever? Transplant Proc 2006;38:473–476.
   PubMed Web of Science ®Google Scholar
• Sobh M, Moustafa F, Hamed S, Ghoneim M. Effect of colchicine on schistosoma-induced renal amyloidosis in Syrian golden hamsters. Nephron 1995;70:478–485.
   Google Scholar
• Livneh A, Shtrasburg S, Langevitz P. Regression of nephrotic syndrome in amyloidosis of familial Mediterranean fever following colchicine treatment. Nephrol Dial Transplant 2000;15:1713–1714.
   PubMedGoogle Scholar
• Sen S, Sarsik B. A proposed histopathologic classification, scoring, and grading system for renal amyloidosis: standardization of renal amyloid biopsy report. Arch Pathol Lab Med 2010;134:532–544.
   PubMed Web of Science ®Google Scholar
• Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol 2006;17:3458–3471.
   PubMed Web of Science ®Google Scholar